PROCOS SPA CONTINUES ITS GROWTH TRAJECTORY FULLY SUPPORTED BY ITS US SUBSIDIARY, PROCOS USA, INC.
27 April 2022
No Comments
Procos USA team will join the upcoming CPhI North America conference
Tag: CDMO
PharmaZell and Novasep announce the creation of a leading CDMO and API manufacturer
11 April 2022
No Comments
PharmaZell, a leading supplier of highly resilient and specialty APIs, and Novasep, a major CDMO focused on complex small molecules and ADCs, announced today the closing of their merger, following exclusive negotiations initiated in September 2021.
INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES, WITH A NEW PRODUCTION PILOT PLANT FOR APIs AND OTHER INNOVATIONS
14 March 2022
No Comments
The CDMO area of business has been one of the priority for Indena’s strategic development for years. Recently, the company invested to implement new cutting-edge technologies, mainly for the expansion of the GMP pilot plant and the upgrade of the …
Procos SpA – Your CDMO from research to manufacturing
14 March 2022
No Comments
Procos believes that state-of-the-art technology will further enhance the timeline for API development and submission to relative regulatory authority such as FDA. This is the reason behind a total investment of one-million Euro to install …
CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity
12 January 2022
No Comments
Continued stellar growth in pharma sales and innovation bode well for supply side companies and CDMOs